Literature DB >> 3960282

Benign myoclonus of early infancy or benign non-epileptic infantile spasms.

C Dravet, N Giraud, M Bureau, J Roger, G Gobbi, B Dalla Bernardina.   

Abstract

Lombroso and Fejerman (1983) described a syndrome which shares with West syndrome the clinical features of flexion spasm with onset in early infancy. However the syndrome differs from West syndrome in the absence of mental and psycho-motor involvement and having a normal EEG during wakefulness and sleep. We report four cases of these benign spasms of early infancy with polygraphic recording of the spasms providing the following information: the spasms are clinically similar to those often observed in West syndrome; namely they are characterized by a short (2-4 sec.) tonic contraction, there are no significant changes of the EEG concomitant to the spasm, series of spasms can occur not only during the daytime but also during sleep and immediately after awakening. Differential diagnosis is discussed with West syndrome and benign myoclonic epilepsy in infancy and with non-epileptic syndromes. The authors propose to name this syndrome: Benign Non-Epileptic Infantile Spasms.

Entities:  

Mesh:

Year:  1986        PMID: 3960282     DOI: 10.1055/s-2008-1052496

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  4 in total

Review 1.  Infantile spasms: review of the literature and personal experience.

Authors:  Alberto Fois
Journal:  Ital J Pediatr       Date:  2010-02-08       Impact factor: 2.638

Review 2.  Myoclonus and epilepsies.

Authors:  N Fejerman
Journal:  Indian J Pediatr       Date:  1997 Sep-Oct       Impact factor: 1.967

3.  Infantile spasms: little seizures, BIG consequences.

Authors:  W Donald Shields
Journal:  Epilepsy Curr       Date:  2006 May-Jun       Impact factor: 7.500

4.  Problems of differentiation between epilepsy and non-epileptic paroxysmal events in the first year of life.

Authors:  A Shuper; M Mimouni
Journal:  Arch Dis Child       Date:  1995-10       Impact factor: 3.791

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.